Skip to main content
. 2023 Nov 8;23(8):4665–4672. doi: 10.1007/s10238-023-01249-0

Fig. 2.

Fig. 2

Therapeutic outcomes of patients according NKCC4. A OS and B PFS. Both OS and PFS rates of patients in the high NKCC4 group were significantly higher than those in the low NKCC4 group (p < 0.0001 for OS and p < 0.0004 for PFS)